Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 125K 116K 107K 203K 13.68M 206K 1.38M 543K 6.74M 538K 527K 23.16M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.07M 18.51M 17.1M 32.45M 2.19B 32.99M 221M 86.87M 1.08B 86.16M 84.29M 3.71B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.59K | |
| +0.94% | +2.52% | +24.76% | +0.76% | 196B | |
| +0.76% | -5.46% | -20.77% | +17.93% | 144B | |
| +0.31% | +2.91% | +0.76% | -16.57% | 141B | |
| -0.12% | +0.31% | -57.12% | -15.25% | 66.54B | |
| +0.02% | -3.36% | +17.50% | -1.19% | 53.09B | |
| +2.73% | +1.98% | -22.66% | -30.53% | 44.12B | |
| -0.56% | +2.07% | +11.01% | +11.69% | 37.93B | |
| -0.23% | -0.96% | +23.37% | +39.37% | 36.96B | |
| +1.58% | +1.35% | -11.73% | -19.27% | 29.43B | |
| Average | +0.56% | -0.75% | -3.88% | -1.45% | 83.21B | |
| Weighted average by Cap. | +0.64% | -0.83% | -1.30% | -0.93% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.51M 1.4M 1.29M 2.45M 165M 2.49M 16.67M 6.55M 81.25M 6.49M 6.35M 279M | 1.98M 1.73M 1.6M 1.47M 2.8M 189M 2.84M 19.07M 7.49M 92.92M 7.43M 7.26M 319M |
| Net income | -16.08M -14.06M -12.97M -11.98M -22.73M -1.53B -23.11M -155M -60.86M -755M -60.36M -59.05M -2.6B | -29.31M -25.64M -23.65M -21.84M -41.45M -2.8B -42.15M -283M -111M -1.38B -110M -108M -4.73B |
| Net Debt | 20.53M 17.95M 16.56M 15.29M 29.02M 1.96B 29.51M 198M 77.7M 964M 77.07M 75.39M 3.32B | 22.8M 19.95M 18.4M 16.99M 32.24M 2.18B 32.79M 220M 86.33M 1.07B 85.63M 83.76M 3.68B |
Employees
-
Choose MarketScreener 
